Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Hepatol. 2016 Nov 2;66(3):545–551. doi: 10.1016/j.jhep.2016.10.029

Fig. 2. Example of clinical response.

Fig. 2

(A) CT scan over 6-month time period for subject 3 showing an increase in the ablated area (denoted A) in addition to changes in tumor size (denoted T) on two separate cuts of the same scan demonstrating worsening appearances at 8 weeks with subsequent improvement and in some cases resolution at 24 weeks. (B) AFP over time for subject 3. (C) CT scan over 6-month time period for subject 10 showing a marked reduction in the tumor area (denoted T) from 10.5 cm at baseline to 4.3 cm after 2 months. Of note, whilst this patient did undergo subtotal TACE the tumor mass shown in the figure was not embolized. (D) AFP over time for subject 10.

HHS Vulnerability Disclosure